The purpose of this purchase order is to procure antibody and diagnostic tests to detect ebola virus in cadavers.
Active Purchase Order Awarded Last action
- Contract number
- 75A50122P00014
- Awardee
-
Orasure Technologies Inc. UEI Y79RWFLHWDM6
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $951,950
Award facts
- Opportunity
-
- Acquisition of Filovirus Point-of-Care (PoC) Diagnostic Tests Solicitation · 75A50122Q00017 · Posted May 19, 2022
- Contract value 51% obligated
-
- $1,190,650.00 Current, with exercised options
- $1,876,050.00 Potential, with all options
- Completion date 87% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fountain Hill, PA 18015, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $143,100 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | -$47,250 | |
| Exercise an Option | $238,700 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $238,700 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $378,700 |
Show all 11
About this award
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a purchase order to OraSure Technologies Inc. valued at $1.876 million on June 22, 2022, for antibody and diagnostic tests to detect Ebola virus in cadavers. The order is firm fixed price with no set-aside designation. Work is performed in Fountain Hill, Pennsylvania. The requirement calls for point-of-care diagnostic tests, specifically handheld lateral flow rapid antigen tests that are FDA authorized or cleared to sample oral fluid from cadavers and detect Ebola virus disease in recently deceased individuals. The order is scheduled for completion by June 22, 2027, and resulted from a BARDA solicitation posted May 19, 2022, requiring award to the lowest-priced technically acceptable offeror.
Quick answers
Who was awarded contract 75A50122P00014?
75A50122P00014 was awarded to Orasure Technologies Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on June 22, 2022.
How much is contract 75A50122P00014 worth?
The government has obligated $951,950 on 75A50122P00014. Its current value, with exercised options, is $1,190,650. Its potential value, with all options, is $1,876,050.
Was contract 75A50122P00014 competed?
The extent of competition for 75A50122P00014 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award